GlassScriptPhysician profile
Aldo A Ghobriel
NPI 1619919289
$6,514.32
in general payments reported to CMS, 2019-2025
31 companies · $315 in 2025
The $315 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $662 · 2020: $114 · 2021: $321 · 2022: $782 · 2023: $1,107 · 2024: $3,213 · 2025: $315.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,361 · Travel and Lodging: $2,209 · Education: $65.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,360.55 |
| Travel and Lodging | $2,209.42 |
| Education | $65.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,868.48 | 2019-2025 | Lumenis Pulse 120h, Moses 550 Dfl, Rezum Generator |
| Procept Biorobotics Corporation | $1,490.96 | 2023-2024 | Aquabeam System, Aquabeam Robotic System |
| Astellas Pharma US INC | $823.40 | 2019-2025 | Myrbetriq, Xtandi |
| Axonics, INC. | $331.58 | 2021-2024 | Axonics, Bulkamid |
| Myriad Genetic Laboratories, INC. | $268.58 | 2023-2025 | Prolaris |
| Dendreon Pharmaceuticals LLC | $204.02 | 2019-2025 | Provenge |
| Sumitomo Pharma America, INC. | $173.32 | 2023-2025 | Orgovyx, Gemtesa |
| Innovation Technologies INC | $166.32 | 2022-2024 | Irrisept |
| Pfizer INC. | $129.11 | 2019-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $121.25 | 2019-2022 | |
| Myovant Sciences INC. | $109.17 | 2021-2022 | |
| Janssen Biotech, INC. | $103.20 | 2019-2025 | Erleada |
| Blue Earth Diagnostics | $78.98 | 2022-2024 | |
| Novartis Pharmaceuticals Corporation | $73.11 | 2023-2025 | |
| Ferring Pharmaceuticals INC. | $65.84 | 2019-2024 | Adstiladrin |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tempus Ai, INC | $58.06 | 2024-2025 | Xt Cdx |
| Neotract INC. | $43.70 | 2019 | |
| Teleflex LLC | $42.82 | 2022 | |
| Endo Pharmaceuticals INC. | $37.15 | 2019-2024 | Xiaflex |
| Urogen Pharma, INC. | $36.37 | 2022-2023 | Jelmyto |
| Olympus America INC. | $36.05 | 2022-2023 | Itind System |
| Antares Pharma, INC. | $35.29 | 2019-2020 | |
| Urovant Sciences INC | $33.64 | 2022 | |
| Foundation Medicine, INC. | $27.44 | 2022 | |
| Biotissue Holdings INC. | $27.05 | 2022 | |
| Coloplast Corp | $26.85 | 2019 | |
| Merck Sharp & Dohme LLC | $25.94 | 2023 | Lynparza, Keytruda |
| Abbvie INC. | $21.68 | 2023 | |
| Progenics Pharmaceuticals, INC. | $19.35 | 2022 | |
| Janssen Scientific Affairs, LLC | $18.39 | 2020 | |
| Medtronic USA, INC. | $17.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aldo Ghobriel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.